Within the skin, red fluorescence from the powder was observed in the epidermis, which was highly significant at days 1 and 2 but declined over days 4 to 8 until all of the powder was ingested (Figure 5 D).
← all excerpts
Co-delivery of targeted hypoallergens and resiquimod powders using silk fibroin microneedles for effective allergen-specific immunotherapy.
1
—
—